TAGGED AS: Product Theater
-
Product Theater: A Closer Look at Taltz
-
Product Theater: A Closer Look at Taltz
-
Product Theater: Dupixent (dupilumab) Injection – The First Biologic for Adults with Controlled Moderate-to-Severe Atopic Dermatitis
-
Product Theater: Dupixent (dupilumab) Injection – The First Biologic for Adults with Controlled Moderate-to-Severe Atopic Dermatitis
-
Product Theater: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab
-
Product Theater: TREMFYA: A Selective IL-23 Inhibitor With Pivotal Studies vs. Adalimumab
-
Product Theater: Introducing a New Innovation in the Treatment of Persistent Facial Erythema
-
Product Theater: Introducing a New Innovation in the Treatment of Persistent Facial Erythema
-
Product Theater: Customizing Treatments for Moderate to Severe Acne Patients
-
Product Theater: Customizing Treatments for Moderate to Severe Acne Patients
-
Summer 2018 | Live Blog | Product Theater | Tremfya: A Selective IL-23 Inhibitor with Pivotal Studies vs. Adalimunab
